Syphilis in the HIV Era by Kassutto, Sigall & Doweiko, John P.
Syphilis in 
the HIV Era
Sigall Kassutto* and John P. Doweiko*
The incidence of syphilis has consistently increased
from 2000 to 2002. We report a case of acquired syphilis
with symptoms of Tullio phenomenon in a patient concur-
rently diagnosed with HIV infection. The resurgence of
syphilis in HIV-positive groups at high risk has public health
implications for prevention of both diseases. 
The Case
A 35-year-old man with an unremarkable medical his-
tory sought treatment for headaches, hearing loss, and
night sweats. The headaches were occipital and bilateral
and had started 3 months earlier. They came on as the day
progressed and were neither positional nor associated with
nausea, vomiting, or visual changes. Three weeks before
arriving at the hospital, he noted a sense of “fullness” in his
ears; he said that spoken voices sounded muffled, and he
had difficulty hearing telephone conversations. When
someone at the restaurant where he worked dropped a dish,
he heard that sound clearly and reported that it was almost
painful, causing him to become dizzy. He otherwise denied
ear pain or recent trauma. His appetite was good, and he
had not lost weight. Although he reported no fever, he did
report night sweats for several weeks. He had no rash, diar-
rhea, abdominal pain, chest pain, shortness of breath, joint
complaints, or dysuria. The patient attributed his
headaches to stress. He also said that he was exposed to
dust at his workplace because of remodeling.
The patient was taking no regular medications and had
no drug allergies. He had quit smoking 7 months earlier
and drank 10–12 beers per week. He reported no history of
intravenous drug use. He lived in New Hampshire, had no
pets, and worked as part owner of a restaurant. Exposures
included multiple male and female sexual partners with
inconsistent condom use, and he had acquired several tat-
toos 8 months earlier while traveling in Spain and Italy. He
had no known tuberculosis exposure. An HIV antibody test
had been negative 18 months earlier.
On physical examination, he appeared healthy but anx-
ious. Temperature was 36.7°C, blood pressure 128/84 mm
Hg, pulse 80, respirations 16/minute. Sclerae were
anicteric, and his pupils reacted to direct and consensual
testing and responded normally to accommodation.
Funduscopic examination showed no retinal abnormalities.
The left tympanic membrane was retracted; both sides
demonstrated a small effusion. No vesicles were seen.
Bedside testing showed that his hearing was diminished to
low volume sounds, but he was able to hear loud sounds,
which he found painful. When the examiner clapped his
hands loudly a few feet from the patient’s ear, the patient
exhibited nystagmus. His sinuses were not tender, and the
oral mucosa had no lesions. The patient’s neck was supple;
a 1.5-cm, nontender lymph node was palpated in the left
upper anterior cervical chain. No other lymphadenopathy
was noted. The remainder of the examination was unre-
markable, with negative Romberg test; normal gait; and
normal motor, sensory, and reflex performance.
Laboratory evaluation (Table) showed low hematocrit
and normal renal and liver function. HIV enzyme-linked
immunosorbent assay and confirmatory test were positive.
Rapid plasma reagin (RPR) was positive at a titer of 1:128
and was confirmed by a fluorescent treponemal antibody
test. Subsequent studies showed a CD4 receptor–positive
T-cell (CD4) count of 899/µL and an HIV viral load of
878 copies/mL. A lumbar puncture showed protein 33
mg/dL, glucose 78 mg/dL, 9 erythrocytes/µL, and 8
leukocytes/µL (100% lymphocytes). Cerebrospinal fluid
venereal disease research laboratory test (CSF-VDRL)
results were negative.
The patient was started on 24 mU of IV penicillin per
day for 14 days. At the end of this period, he reported
notable improvement in his headaches, hearing loss, and
vertiginous symptoms. One month after completing treat-
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Table. Selected laboratory  test results 1 month after therapy for 
neurosyphilis in HIV-positive patient with neurosyphilis
a
 
Laboratory test   Result 
Complete blood count    
Leukocytes  5,700/µL 
Hematocrit  36% 
Platelets  295,000/µL 
Electrolytes and renal fu nction tests  Within normal limits  
Liver function tests   Within normal limits  
Cerebrospinal fluid evaluation    
Leukocytes  8 cells/µL 
Differential  100% lymphocytes  
Erythrocytes  9 cells/µL 
Protein  33 mg/dL 
Glucose  78 mg/dL 
CSF-VDRL  Negative 
HIV-1 testing   
ELISA + WB  Positive 
CD4 count  899 cells/µL 
Viral load (RT -PCR)  878 copies/µL 
Rapid plasma reagin testing    
Baseline  1:128 
1 month posttreatment   1:32 
3 months posttreatment   Nonreactive 
aCSF-VDRL, cerebrospinal fluid venereal disease research labo ratory test; 
ELISA, enzyme-linked immunosorbent assay; WB, Western blot; RT -PCR, 
reverse transcription –polymerase chain reaction.  ment, his RPR titer was 1:32; 3 months after he completed
treatment, it was nonreactive. 
Conclusions
The course of syphilis in an HIV-positive patient may
be altered from the natural history of the disease in HIV-
negative patients. An increased frequency of ocular dis-
ease, multiple and slower resolving primary chancres, and
a higher titer RPR have been reported (1–6). In addition,
delay or failure of titer decline after treatment, predilection
for developing the Jarisch-Herxheimer reaction, and clini-
cal relapse have also been described in HIV infection
(1,4,7,8).
Treponema pallidum is thought to invade the central
nervous system in 25% of patients with syphilis, irrespec-
tive of HIV status (9). Most of these persons successfully
clear the infection (10), but other patients harbor the spiro-
chete and remain at risk for sequelae of neurosyphilis.
Syphilitic meningitis, meningovascular disease (often
occurring with stroke), labyrinthitis, or cranial nerve
palsies, as seen in this case, can be early findings. 
The Tullio phenomenon is vestibular hypersensitivity to
sound. In this condition, loud sounds or even routine
acoustic stimuli can result in vertigo, nystagmus, or nausea
and vomiting. The physiologic underpinnings of the Tullio
phenomenon were first described in 1929, when Tullio
noted that experimentally induced fenestrations in the bony
capsule of the lateral semicircular canals of pigeons caused
the canals to be sound-responsive, inducing vestibular acti-
vation (11,12). Shortly thereafter, Benjamins described a
Tullio reaction in a human patient with fistulizing
cholesteatoma (13). Today, the term has been generalized to
include vestibular activation in response to stimulation by
sound of any part of the vestibular apparatus (12).
The Tullio phenomenon is seen in a range of clinical
contexts, including congenital deafness, Meniere disease,
suppurative middle ear disease, and spirochetal infections,
such as syphilis or Lyme disease. Nields et al. describe a
woman who had nystagmus and vertigo with routine
sounds; running tap water caused her to fall to the floor or
retch in pain (14). Watson et al. describe a series of patients
with oscillopsia induced by pencil tapping, telephone ring-
ing, or the sound of cutlery falling on the floor. Patients
often report a vague sense of ear blockage and an unpleas-
ant awareness of their own voice vibrating in their ear (12). 
Symptomatic cranial nerve VIII involvement in this
patient prompted treatment for neurosyphilis, despite
equivocal (but typical) CSF findings. Interpreting CSF
findings in HIV-positive patients with syphilis is challeng-
ing because commonly encountered mild lymphocytic
pleocytosis may be attributable to HIV. CSF-VDRL is
often negative, with a 20%–70% false-negative rate (15).
Optimally managing patients with HIV and syphilis has
been debated; to date routine recommendations are the
same as for HIV-negative persons (16). Although any
patient in whom syphilis is diagnosed and who has neuro-
logic symptoms should undergo lumbar puncture, CSF
evaluation should also be considered in asymptomatic
patients in whom syphilis is diagnosed and who have an
RPR titer >1:32 or a CD4+ count <350, as these markers
have been associated with increased risk for neurosyphilis
(10). Because of the high rate of relapse that has been
reported in some series (4,7,8), close clinical and serolog-
ic follow-up is essential. Whether T. pallidum eradication
is impaired in HIV coinfection remains controversial. A
study of 59 patients with neurosyphilis showed that HIV-
positive study participants were 2.5 times less likely to
normalize CSF-VDRL reactivity than HIV-negative
patients. This effect was even more pronounced in patients
with CD4+ counts <200 (17). The findings suggest that
more intensive therapy for neurosyphilis in immunocom-
promised patients merits further study.
After an all-time low case-rate of syphilis in 2000,
reports of rising trends, specifically in groups at risk, such
as men who have sex with men, were reported in 2001
(18). The outbreaks marked a 9.1% overall increased rate
of primary and secondary syphilis (19) and were character-
ized by a high rate of HIV infection. Parallel increases in
HIVinfection rates were a concern because of the common
mechanism of transmission and the increased efficiency of
HIV transmission with coexistent genital ulcers (20). In
2001, increases in HIV rates were reported in several states
with large urban populations; men who have sex with men
accounted for the largest known subgroup at risk in inci-
dent adult or adolescent HIV cases (32%) and AIDS cases
(44%) (21). New HIV diagnoses increased in 29 states
with mandatory reporting from 1999 to 2002, notably by
17% among gay and bisexual men (22). Syphilis incidence
also continued to rise in the United States in 2002, with a
12.4% increase since 2001 (19), and the highest trends
were estimated to be among men who have sex with men.
In San Francisco, primary and secondary syphilis rates
increased by >1,000% from 1998 to 2002 among men who
have sex with men (23). High-risk behaviors have been
documented in this group (24) and factor prominently in
syphilis reemergence in the early 21st century.
This case report describes a patient who had Tullio phe-
nomenon as the index symptom of neurosyphilis with pre-
viously undiagnosed HIV infection. His RPR titer was
1:128, his CD4 count was preserved, and he responded
well clinically and serologically to standard therapy. To
our knowledge, this case is the first report of syphilis
occurring as Tullio phenomenon in an HIV-positive
patient. We suggest that syphilis be considered in patients
who have cranial nerve VIII symptoms and an appropriate
risk-factor profile. Eradicating treponemes may be limited
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syphilis likely depends not only on antimicrobial effect but
also on host immune response, routine surveillance is a
mainstay of therapy, particularly in patients with HIV
infection. Awareness of unusual symptoms of a relatively
common disease will benefit not only the patient but also
public health efforts in managing both syphilis and HIV
infection. Preventive and educational efforts focused on
men who have sex with men may prove particularly impor-
tant in modifying behaviors that foster the growth of both
epidemics.
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